Dipivefrin

Dipivefrin
(IUPAC) ime
	[2-(2,2-dimetilpropanoiloksi)-4- (1-hidroksi-2-metilamino-etil)- fenil] 2,2-dimetilpropanoat
Klinički podaci
AHFS/Drugs.com	Internacionalno ime leka
MedlinePlus	a686005
Identifikatori
CAS broj	52365-63-6
ATC kod	S01EA02
PubChem	3105
DrugBank	DB00449
ChemSpider	2994
UNII	8Q1PVL543G
KEGG	D02349
ChEBI	CHEBI:4646
ChEMBL	CHEMBL1201262
Hemijski podaci
Formula	C19H29NO5
Mol. masa	351,437 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C19H29NO5/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6/h8-10,13,20-21H,11H2,1-7H3 ; Key: OCUJLLGVOUDECM-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	B(US)
Pravni status

Dipivefrin je prolek epinefrina koji se koristi za tretiranje glaukoma. On je dostupan kao oftalmički rastvor. Dipivefrin uzrokuje vazokonstrikciju, smanjuje proizvodnju očne tečnosti, i redukuje intraočni pritisak. On se konvertuje u epinefrin nakon penetracije korneje.^[6]

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Paul Diggory, Wendy Franks (1996). „Medical treatment of glaucoma - a reappraisal of the risks”. British Journal of Ophthalmology 80: 85-89.

Vanjske veze

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] Paul Diggory, Wendy Franks (1996). „Medical treatment of glaucoma - a reappraisal of the risks”. British Journal of Ophthalmology 80: 85-89.

[1]

[2]

[3]

[4]

[5]

[6]